In this study, we show the differential ER distribution events and differential expression profile in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells and further demonstrate that the ER signaling pathway in tamoxifen-resistant breast cancer cells is also E2-dependent. Here, ESR1 is linked to breast carcinoma.